A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

Name: A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)
License: Public Domain

AIM Vaccine Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

sars-cov-2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 343699
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.